Total Payments
$18,613
2024 Payments
$7,012
Companies
10
Transactions
27
Medicare Patients
1,572
Medicare Billing
$269,420

Payment Breakdown by Category

Consulting$16,796 (90.2%)
Travel$935.00 (5.0%)
Food & Beverage$862.20 (4.6%)
Education$20.05 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $16,796 9 90.2%
Travel and Lodging $935.00 3 5.0%
Food and Beverage $862.20 14 4.6%
Education $20.05 1 0.1%

Top Paying Companies

Company Total Records Latest Year
E.R. Squibb & Sons, L.L.C. $7,277 7 $0 (2024)
Janssen Biotech, Inc. $5,526 4 $0 (2024)
Janssen Scientific Affairs, LLC $4,115 3 $0 (2024)
Janssen Research & Development, LLC $1,095 6 $0 (2023)
Adaptive Biotechnologies Corporation $201.85 2 $0 (2022)
Genmab U.S., Inc. $157.10 1 $0 (2024)
Dr.Reddy's Laboratories,Inc. $100.00 1 $0 (2018)
GENZYME CORPORATION $92.67 1 $0 (2024)
Genentech USA, Inc. $28.43 1 $0 (2019)
PFIZER INC. $20.05 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $7,012 7 Janssen Scientific Affairs, LLC ($3,025)
2023 $6,948 10 E.R. Squibb & Sons, L.L.C. ($4,763)
2022 $125.43 2 Adaptive Biotechnologies Corporation ($64.30)
2021 $4,253 3 Janssen Biotech, Inc. ($4,115)
2019 $28.43 1 Genentech USA, Inc. ($28.43)
2018 $120.05 2 Dr.Reddy's Laboratories,Inc. ($100.00)
2017 $127.28 2 E.R. Squibb & Sons, L.L.C. ($127.28)

All Payment Transactions

27 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
12/09/2024 Genmab U.S., Inc. Epkinly (Drug) Food and Beverage In-kind items and services $157.10 General
Category: Oncology
12/06/2024 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $15.00 General
11/01/2024 Janssen Biotech, Inc. TALVEY (Biological) Consulting Fee Cash or cash equivalent $1,350.00 General
Category: Oncology
10/14/2024 Janssen Scientific Affairs, LLC TECVAYLI (Biological) Consulting Fee Cash or cash equivalent $1,375.00 General
Category: Oncology
04/11/2024 GENZYME CORPORATION SARCLISA (Biological) Food and Beverage In-kind items and services $92.67 General
Category: Oncology
03/12/2024 E.R. Squibb & Sons, L.L.C. Consulting Fee Cash or cash equivalent $2,372.00 General
02/21/2024 Janssen Scientific Affairs, LLC TECVAYLI (Biological) Consulting Fee Cash or cash equivalent $1,650.00 General
Category: Oncology
12/11/2023 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $9.93 General
12/07/2023 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $9.22 General
08/10/2023 E.R. Squibb & Sons, L.L.C. Consulting Fee Cash or cash equivalent $4,744.00 General
05/25/2023 Janssen Scientific Affairs, LLC DARZALEX (Biological) Consulting Fee Cash or cash equivalent $1,090.00 General
Category: Oncology
03/24/2023 Janssen Research & Development, LLC CARVYKTI (Drug) Travel and Lodging In-kind items and services $286.75 General
Category: Oncology
03/24/2023 Janssen Research & Development, LLC CARVYKTI (Drug) Travel and Lodging In-kind items and services $220.10 General
Category: Oncology
03/23/2023 Janssen Research & Development, LLC CARVYKTI (Drug) Food and Beverage In-kind items and services $97.64 General
Category: Oncology
03/23/2023 Janssen Research & Development, LLC CARVYKTI (Drug) Food and Beverage In-kind items and services $34.58 General
Category: Oncology
03/23/2023 Janssen Research & Development, LLC CARVYKTI (Drug) Food and Beverage In-kind items and services $27.37 General
Category: Oncology
03/08/2023 Janssen Research & Development, LLC CARVYKTI (Drug) Travel and Lodging In-kind items and services $428.15 General
Category: Oncology
12/10/2022 Adaptive Biotechnologies Corporation clonoSEQ (Device) Food and Beverage In-kind items and services $64.30 General
Category: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
12/09/2022 Janssen Biotech, Inc. TECVAYLI (Biological) Food and Beverage In-kind items and services $61.13 General
Category: Oncology
11/17/2021 Adaptive Biotechnologies Corporation clonoSEQ (Device) Food and Beverage In-kind items and services $137.55 General
Category: B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
10/19/2021 Janssen Biotech, Inc. DARZALEX (Biological) Consulting Fee Cash or cash equivalent $2,750.00 General
Category: Oncology
07/14/2021 Janssen Biotech, Inc. DARZALEX (Biological) Consulting Fee Cash or cash equivalent $1,365.00 General
Category: Oncology
12/09/2019 Genentech USA, Inc. GAZYVA (Biological) Food and Beverage In-kind items and services $28.43 General
Category: BioOncology
08/08/2018 Dr.Reddy's Laboratories,Inc. Consulting Fee Cash or cash equivalent $100.00 General
05/25/2018 PFIZER INC. MYLOTARG (Biological) Education In-kind items and services $20.05 General
Category: ONCOLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 444 875 $328,286 $81,629
2022 8 421 853 $280,128 $74,377
2021 9 356 685 $226,779 $61,926
2020 10 351 686 $205,808 $51,488
Total Patients
1,572
Total Services
3,099
Medicare Billing
$269,420
Procedure Codes
36

All Medicare Procedures & Services

36 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 109 352 $159,847 $38,464 24.1%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 41 137 $40,175 $12,960 32.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 91 131 $42,993 $9,173 21.3%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2023 43 43 $24,897 $6,030 24.2%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 26 69 $14,007 $4,339 31.0%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2023 32 32 $14,656 $3,163 21.6%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 20 21 $11,907 $2,790 23.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 54 60 $13,698 $2,781 20.3%
99238 Hospital discharge day management, 30 minutes or less Facility 2023 28 30 $6,106 $1,928 31.6%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 105 298 $120,118 $32,738 27.3%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 55 193 $56,012 $15,808 28.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 88 122 $36,564 $8,476 23.2%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 44 101 $20,350 $5,764 28.3%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2022 34 34 $19,524 $4,782 24.5%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 17 17 $9,575 $2,694 28.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 52 61 $12,546 $2,562 20.4%
99238 Hospital discharge day management, 30 minutes or less Facility 2022 26 27 $5,439 $1,554 28.6%
99215 Established patient outpatient visit, total time 40-54 minutes Facility 2021 83 249 $95,316 $27,470 28.8%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 40 138 $39,378 $11,400 29.0%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 85 116 $33,021 $7,504 22.7%
99205 New patient outpatient visit, total time 60-74 minutes Facility 2021 34 34 $18,717 $4,928 26.3%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 23 55 $10,875 $3,162 29.1%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 17 17 $9,426 $2,723 28.9%
99204 New patient outpatient visit, total time 45-59 minutes Facility 2021 22 22 $9,376 $2,190 23.4%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 39 41 $8,104 $1,797 22.2%

About Dr. Laahn Foster, M.D

Dr. Laahn Foster, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Charlottesville, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/08/2011. The National Provider Identifier (NPI) number assigned to this provider is 1699071696.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Laahn Foster, M.D has received a total of $18,613 in payments from pharmaceutical and medical device companies, with $7,012 received in 2024. These payments were reported across 27 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($16,796).

As a Medicare-enrolled provider, Foster has provided services to 1,572 Medicare beneficiaries, totaling 3,099 services with total Medicare billing of $269,420. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.

Practice Information

Products in Payments

  • DARZALEX (Biological) $5,205
  • TECVAYLI (Biological) $3,086
  • TALVEY (Biological) $1,350
  • CARVYKTI (Drug) $1,095
  • clonoSEQ (Device) $201.85
  • Epkinly (Drug) $157.10
  • SARCLISA (Biological) $92.67
  • GAZYVA (Biological) $28.43
  • MYLOTARG (Biological) $20.05

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Charlottesville